UBS AM
VXRT

UBS AM’s Vaxart VXRT Stock Holding History

UBS AM’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-201,150
Closed -$439K – 2739
2022
Q3 		$439K Buy
201,150
+91,006
+83% +$314K ﹤0.01% 2386
2022
Q2 		$386K Sell
110,144
-6,685
-6% -$25K ﹤0.01% 2390
2022
Q1 		$589K Hold
116,829
– – ﹤0.01% 2398
2021
Q4 		$733K Buy
116,829
+6,680
+6% +$45.6K ﹤0.01% 2365
2021
Q3 		$876K Hold
110,149
– – ﹤0.01% 2237
2021
Q2 		$825K Buy
110,149
+4,047
+4% +$28.3K ﹤0.01% 2317
2021
Q1 		$642K Buy
106,102
+3,302
+3% +$25.4K ﹤0.01% 2296
2020
Q4 		$587K Buy
+102,800
New +$654K ﹤0.01% 2246

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS AM's VXRT Position: Q4 2022 in Review

UBS AM sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 201,150 shares — an estimated $439K sold.

UBS AM first reported a position in VXRT in Q4 2020 and held it in 8 quarters. The position peaked at $876K in Q3 2021. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • UBS AM reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • UBS AM sold 201,150 Vaxart shares in Q4 2022, an estimated $439K.
  • UBS AM first reported a position in Vaxart in Q4 2020 and held it in 8 quarters.
  • UBS AM's Vaxart position peaked at $876K in Q3 2021.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.